SCHEMBL27398649

SCHEMBL27398649

COc1cncc(-c2c(N)c(C(N)=O)nc3cccnc23)c1C

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MKNK1 Q9BUB5 2/20 0.35
▸ MKNK2 Q9HBH9 2/20 0.35
▸ IKBKB O14920 1/20 0.35
▸ LCK P06239 1/20 0.35
▸ BTK Q06187 1/20 0.35
▸ PDE4B Q07343 2/20 0.35
▸ BRD4 O60885 1/20 0.35
▸ CYP3A4 P08684 1/20 0.35
▸ CYP2C9 P11712 1/20 0.35
▸ BRD2 P25440 1/20 0.35
▸ CYP2C19 P33261 1/20 0.35
▸ BRD3 Q15059 1/20 0.35
▸ KDM4E B2RXH2 3/20 0.34
▸ ALDH1A1 P00352 1/20 0.34
▸ PKMYT1 Q99640 1/20 0.34
▸ PRMT5 O14744 1/20 0.34
▸ MAPT P10636 2/20 0.33
▸ RAB9A P51151 2/20 0.33
▸ ATM Q13315 2/20 0.33
▸ PLAU P00749 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30905539 0.87 IKBKB (0.41) MKNK1MKNK2IKBKBPDE4BBRD4
SCHEMBL27397408 0.87 IKBKB (0.41) MKNK1MKNK2IKBKBPDE4BBRD4
SCHEMBL27398651 0.86 LCK (0.37) MKNK1MKNK2IKBKBLCKBTK
SCHEMBL27399330 0.85 DHODH (0.39) MKNK1MKNK2LCKBTKPRMT5
SCHEMBL27399923 0.84 BRD4 (0.35) MKNK1MKNK2IKBKBPDE4BBRD4
SCHEMBL27400738 0.82 LCK (0.37) MKNK1MKNK2LCKBTKPKMYT1
SCHEMBL27399600 0.82 IRAK4 (0.35) MKNK1MKNK2IKBKBLCKBTK
SCHEMBL27401362 0.82 PKMYT1 (0.44) IKBKBPDE4BKDM4EALDH1A1PKMYT1
SCHEMBL27399014 0.81 LCK (0.51) MKNK1MKNK2IKBKBLCKBTK
SCHEMBL27399603 0.81 MKNK1 (0.40) MKNK1MKNK2IKBKBLCKBTK

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2024112853-A1 COMPOUNDS THAT INHIBIT PKMYT1 EXELIXIS, INC. (US) 2024-05-30 — — WO disclosed
Send feedback